[In reference to "Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market”]. FE [Internet]. 2017 Sep. 12 [cited 2025 Oct. 29];18(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1315